BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8948669)

  • 1. Primary extramedullary leukemia of the prostate: case report and review of the literature.
    Quien ET; Wallach B; Sandhaus L; Kidd P; Strair R; Saidi P
    Am J Hematol; 1996 Dec; 53(4):267-71. PubMed ID: 8948669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary, highly malignant B-cell lymphoma of the prostate. Apropos of a case and review of the literature].
    Mounedji-Boudiaf L; Culine S; Devoldère G; Terrier-Lacombe MJ; Kattan J; Cazier A; Farhat F; Bekradda M; Droz JP
    Bull Cancer; 1994 Apr; 81(4):334-7. PubMed ID: 7703552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Granulocytic sarcoma of the prostate presenting with urinary obstruction which progressed to acute myeloid leukemia].
    Tsuboi K; Kawada H; Suzuki R; Murayama H; Ohmachi K; Nakamura N; Ogawa Y; Ando K
    Rinsho Ketsueki; 2008 Nov; 49(11):1562-5. PubMed ID: 19047789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic extramedullary leukemia as a first site of relapse of acute nonlymphocytic leukemia.
    Anderson GA; Braaten K
    Urol Oncol; 2005; 23(6):419-21. PubMed ID: 16301120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary non-Hodgkin's lymphoma of the prostate].
    Swierz J; Zieliński H; Dabek A
    Pol Merkur Lekarski; 1996 Oct; 1(4):278-9. PubMed ID: 9156946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rhabdomyosarcoma of the prostate in childhood: a case report].
    Okumura A; Fujiuchi Y; Yokoyama T; Ohta S; Nozaki T; Watanabe A; Fuse H; Koizumi H
    Hinyokika Kiyo; 1998 Aug; 44(8):611-4. PubMed ID: 9783202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and therapeutic management of gastric lymphomas].
    Grau E; Perella M; Gómez A; Pastor E; Mirabet MD; García F; Ibáñez JL; Aguiló J
    Sangre (Barc); 1996 Apr; 41(2):109-14. PubMed ID: 9045350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocytic sarcoma in the absence of acute myeloid leukemia: a case report.
    Khalid S; Adil SN; Vaziri IA
    Indian J Pathol Microbiol; 2007 Jan; 50(1):88-90. PubMed ID: 17474271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
    Federico M; Clò V; Brugiatelli M; Carotenuto M; Gobbi PG; Vallisa D; Lombardo M; Avanzini P; Di Renzo N; Dini D; Baldini L; Silingardi V
    Haematologica; 1998 Sep; 83(9):800-11. PubMed ID: 9825577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful treatment with idarubicin in a pediatric case of t(8;21) acute myelogenous leukemia with additional chromosomal abnormalities at relapse].
    Wakazono Y; Kataoka A; Fusaoka T; Tunamoto K
    Rinsho Ketsueki; 1998 Jul; 39(7):499-505. PubMed ID: 9750457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
    Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocytic sarcoma of the ovary in a nonleukemic patient.
    Aguiar RC; Pozzi DH; Chamone DA
    Haematologica; 1993; 78(1):53-5. PubMed ID: 8491421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of primary extramedullary leukemia (EML) of the uterus with radical surgery, chemotherapy, autologous bone marrow transplantation (BMT) and prophylactic local irradiation.
    Huter O; Brezinka C; Nachbaur D; Schwaighofer H; Lang A; Niederwieser D
    Bone Marrow Transplant; 1996 Sep; 18(3):663-4. PubMed ID: 8879638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
    Yavuz S; Paydas S; Disel U; Sahin B
    Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results in non randomized patients with acute myelogenous leukemia: a single institution experience.
    Deliliers GL; Annaloro C; Oriani A; Della Volpe A; Boschetti C; Cortelezzi A; Maiolo AT
    Ann Ital Med Int; 1998; 13(3):146-51. PubMed ID: 9859570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of primary malignant lymphoma of the prostate presenting as urinary retention].
    Kinouchi T; Kinoshita T; Kobayashi M; Ueda T; Inoue H; Takada T; Hara T
    Hinyokika Kiyo; 2010 Oct; 56(10):589-92. PubMed ID: 21063166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia.
    Bassan R; Lerede T; Buelli M; Borleri G; Bellavita P; Rambaldi A; Barbui T
    Haematologica; 1998 May; 83(5):422-7. PubMed ID: 9658726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].
    Rodríguez JN; Fernández-Jurado A; Martino ML; Diéguez JC; Moreno MV; Quesada JA; Polo B; Cañavate M; Amian A; Prados D
    Sangre (Barc); 1998 Feb; 43(1):35-9. PubMed ID: 9580427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.